Age = 18 years of either gender
Written informed consent must be obtained before any intravitreal injection of bevacizumab is performed
Visual impairment predominantly due to abnormal new vessel ingrowth and/or macular edema. The presence of fluid (intraretinal, subretinal or sub-RPE) detected clinically or on the ocular coherence tomography.
